Japans has been eading the Cell therapy movement.
America has been protecting its Big Pharmas and is restrained by red tape and has made recent moves to accelerate for unmet needs via the FDA and 21st Century Act.
China is now in the race and will move swiftly to take products to market via its recent regulatory changes.
With the above in mind, its only a matter of time before very advanced companies like Mesoblast are either swollowed more so for the Intellectual Property.
MSB Trading - 2019, page-23
-
- There are more pages in this discussion • 4,402 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.040(4.52%) |
Mkt cap ! $1.061B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $2.733M | 2.981M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 22817 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 28853 | 12 |
View Market Depth
| Last trade - 11.53am 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |